Thorazine had a market value of approximately $120 million for the 12 months ended November 2020, according to IQVIA, although actual generic market values are expected to be lower.
The National Association of Chain Drug Stores held a media briefing to discuss the essential role of pharmacies and pharmacists in administering the COVID-19 vaccine, following the kickoff of the federal retail pharmacy program.
The National Association of Chain Drug Stores told the DEA in written comments that partial filling of Schedule II controlled substances is a necessary step to help address the opioid-abuse epidemic.